Neoadjuvant chemotherapy in invasive lobular carcinoma of the breast: perspectives based on the survival outcomes
{{output}}
Whether patients with invasive lobular carcinoma (ILC) can benefit from neoadjuvant chemotherapy (NAC) remains uncertain. In order to attempt to bring some light on the matter, the patients treated for ILC between 1998 and 2016 at a tertiary center specialized... ...
